The Board of Directors of Hau Giang Pharmaceutical Joint Stock Company (DHG) has approved the business plan for 2024. The company aims to achieve approximately x billion VND in revenue and an estimated net profit of y billion VND, representing growth compared to the previous year. These targets are set based on market growth forecasts in the pharmaceutical sector, as well as strategies for market expansion and production process improvements. The Board emphasizes the importance of enhancing product quality and customer service while reducing costs to improve operational efficiency. This plan will be presented at the upcoming Annual General Meeting of Shareholders (AGM) for 2024.
Leave a Reply